Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Prepaid Assets (2021 - 2025)

Valion Bio has reported Prepaid Assets over the past 5 years, most recently at $346000.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 44.17% year-over-year to $346000.0; the TTM value through Dec 2025 reached $346000.0, up 44.17%, while the annual FY2025 figure was $346000.0, 44.17% up from the prior year.
  • Prepaid Assets for Q4 2025 was $346000.0 at Valion Bio, up from $135000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $793000.0 in Q4 2021 and troughed at $135000.0 in Q2 2025.
  • A 5-year average of $323687.5 and a median of $274000.0 in 2023 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: tumbled 70.37% in 2022 and later skyrocketed 44.17% in 2025.
  • Year by year, Prepaid Assets stood at $793000.0 in 2021, then crashed by 70.37% to $235000.0 in 2022, then surged by 39.15% to $327000.0 in 2023, then fell by 26.61% to $240000.0 in 2024, then skyrocketed by 44.17% to $346000.0 in 2025.
  • Business Quant data shows Prepaid Assets for TIVC at $346000.0 in Q4 2025, $135000.0 in Q2 2025, and $273000.0 in Q1 2025.